Avalon Pharmaceuticals Cash Flow Statement
View: Annual
| Dec 08 | Dec 07 | Dec 06 | |
|---|---|---|---|
| Net Operating Cash Flow | (18.4) | (19.0) | (11.9) |
| Net Investing Cash Flow | 21.2 | (4.6) | 0.4 |
| Net Financing Cash Flow | (4.1) | 26.8 | 4.9 |
| Net Change in Cash | (1.4) | 3.2 | (6.6) |
| Depreciation & Amortization | 1.6 | 2.0 | 2.4 |
| Capital Expenditures | (0.3) | (0.4) | (0.4) |
| Cash Dividends Paid | -- | -- | -- |
© 2009 Morningstar, Inc. Financial Data provided by
